Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study

Acute myeloid leukemia (AML) with FLT3-mutation carries a poor prognosis, and allogeneic stem cell transplantation (allo-SCT) is recommended at first complete remission (CR1). We assessed 462 adults (median age 50 years) with FLT3-mutated AML allografted between 2010 and 2015 from a matched related...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazarbachi, Ali, Labopin, Myriam, Battipaglia, Giorgia, Djabali, Azedine, Forcade, Edouard, Arcese, William, Socié, Gerard, Blaise, Didier, Halter, Joerg, Gerull, Sabine, Cornelissen, Jan J., Chevallier, Patrice, Maertens, Johan, Schaap, Nicolaas, El-Cheikh, Jean, Esteve, Jordi, Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432385/
https://www.ncbi.nlm.nih.gov/pubmed/34595412
http://dx.doi.org/10.2991/chi.d.190310.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432385/
https://www.ncbi.nlm.nih.gov/pubmed/34595412
http://dx.doi.org/10.2991/chi.d.190310.001

Ejemplares similares